Boehringer Ingelheim GmbH - Company Profile and SWOT Analysis
SummaryBoehringer Ingelheim GmbH - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Boehringer Ingelheim GmbH (Boehringer or 'the company) is a privately held pharmaceuticals and animal health business group. The company offers a wide range of prescription medicines, biopharmaceutical products and animal healthcare products. It also conducts developments, research and manufacture of pharmaceuticals. Boehringer's products find application in the treatment of respiratory diseases, central nervous system disorders, metabolic disorders, cardiovascular diseases, urological and viral conditions, cancer among others. It operates facilities for manufacturing pharmaceutical products, medical products, and chemical active substances. Boehringer operates in Europe, the Americas, Asia, Australia and Africa. The company is headquartered in Ingelheim, Rheinland-Pfalz, Germany.
Scope
Boehringer Ingelheim GmbH - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Boehringer Ingelheim GmbH (Boehringer or 'the company) is a privately held pharmaceuticals and animal health business group. The company offers a wide range of prescription medicines, biopharmaceutical products and animal healthcare products. It also conducts developments, research and manufacture of pharmaceuticals. Boehringer's products find application in the treatment of respiratory diseases, central nervous system disorders, metabolic disorders, cardiovascular diseases, urological and viral conditions, cancer among others. It operates facilities for manufacturing pharmaceutical products, medical products, and chemical active substances. Boehringer operates in Europe, the Americas, Asia, Australia and Africa. The company is headquartered in Ingelheim, Rheinland-Pfalz, Germany.
Reasons To Buy
- Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
- Intelligence on Boehringer Ingelheim GmbH's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.